Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate
The <i>N</i>,<i>C</i>-coupled naphthylisoquinoline alkaloid ancistrocladinium A belongs to a novel class of natural products with potent antiprotozoal activity. Its effects on tumor cells, however, have not yet been explored. We demonstrate the antitumor activity of ancistroc...
Saved in:
Main Authors: | Daniela Brünnert (Author), Raina Seupel (Author), Pankaj Goyal (Author), Matthias Bach (Author), Heike Schraud (Author), Stefanie Kirner (Author), Eva Köster (Author), Doris Feineis (Author), Ralf C. Bargou (Author), Andreas Schlosser (Author), Gerhard Bringmann (Author), Manik Chatterjee (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
by: Noah M. Merin, et al.
Published: (2014) -
Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells
by: Marta Pelon, et al.
Published: (2024) -
Signal mining of adverse events of proteasome inhibitors in multiple myeloma based on FAERS
by: Yuan Peng, et al.
Published: (2024) -
Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells
by: Maiko Matsushita, et al.
Published: (2023) -
Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells
by: Joelle C. Boulos, et al.
Published: (2021)